Transaction in Own Shares

Spire Healthcare Group PLC

04 November 2024

 

4 November 2024

Spire Healthcare Group plc

Transaction in own shares

Spire Healthcare Group plc (the "Company") announces that, in accordance with the terms of its share buyback programme announced on 31 October 2024 (the "Share Buyback Programme") and the authority granted by its shareholders at the Company's 2024 Annual General Meeting held on 9 May 2024, it has purchased the following number of its ordinary shares of 1 pence each ("Shares") on the London Stock Exchange through Numis Securities Limited ("Deutsche Numis"):

Date of purchase:	1 November 2024
Number of Shares purchased:	50,000
Highest price paid per Share (GBp):	220.50
Lowest price paid per Share (GBp):	215.75
Volume weighted average price paid per Share (GBp):	217.6636
Broker:	Deutsche Numis
Trading venue:	London Stock Exchange

The purchased Shares will be cancelled.

Following the purchase of these Shares, the remaining number of Shares in issue will be 404,088,352. The Company does not hold any Shares in treasury. Therefore, the total number of voting rights in the Company is 404,088,352. This figure may be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Deutsche Numis as part of the Share Buyback Programme:

Date of purchase	Number of ordinary shares purchased	Transaction price (GBp share)	Time of transaction (UK Time)	Transaction reference number	Trading venue
1 November 2024	115	216.00	09:37:09	00072180336TRLO0	XLON
1 November 2024	357	216.00	09:37:09	00072180335TRLO0	XLON
1 November 2024	399	216.00	09:37:47	00072180342TRLO0	XLON
1 November 2024	46	216.00	09:37:47	00072180343TRLO0	XLON
1 November 2024	20000	215.75	09:37:55	00072180346TRLO0	XLON
1 November 2024	2097	216.50	10:36:03	00072182443TRLO0	XLON
1 November 2024	1789	218.50	10:46:46	00072182919TRLO0	XLON
1 November 2024	277	218.50	10:46:46	00072182920TRLO0	XLON
1 November 2024	277	218.50	10:46:46	00072182921TRLO0	XLON
1 November 2024	1800	218.50	10:46:46	00072182922TRLO0	XLON
1 November 2024	371	218.50	10:46:46	00072182923TRLO0	XLON
1 November 2024	452	219.00	10:52:57	00072183052TRLO0	XLON
1 November 2024	218	219.00	10:52:57	00072183053TRLO0	XLON
1 November 2024	519	219.00	10:52:57	00072183054TRLO0	XLON
1 November 2024	2318	218.00	11:00:54	00072183301TRLO0	XLON
1 November 2024	741	219.00	11:49:47	00072186039TRLO0	XLON
1 November 2024	450	219.00	11:49:47	00072186040TRLO0	XLON
1 November 2024	500	219.00	11:49:47	00072186041TRLO0	XLON
1 November 2024	4200	219.50	13:18:03	00072188768TRLO0	XLON
1 November 2024	2236	219.50	13:48:48	00072190407TRLO0	XLON
1 November 2024	2007	219.50	15:08:39	00072194489TRLO0	XLON
1 November 2024	1163	219.00	15:15:48	00072194934TRLO0	XLON
1 November 2024	450	220.50	15:39:57	00072196007TRLO0	XLON
1 November 2024	514	220.50	15:39:57	00072196008TRLO0	XLON
1 November 2024	2026	220.00	15:40:22	00072196028TRLO0	XLON
1 November 2024	1115	219.50	16:05:42	00072197208TRLO0	XLON
1 November 2024	939	219.50	16:05:42	00072197209TRLO0	XLON
1 November 2024	1194	219.50	16:05:42	00072197210TRLO0	XLON
1 November 2024	1430	220.00	16:09:37	00072197421TRLO0	XLON

This announcement will also be available on the Company's website at:

https://investors.spirehealthcare.com/news/regulatory-news/

Enquiries:

Spire Healthcare

Harbant Samra, CFO                                                     [phone]

Instinctif Partners

Julian Walker                                                                 [phone]

Registered Office and Head Office:

Spire Healthcare Group plc

3 Dorset Rise

London

EC4Y 8EN

Registered number 09084066

About Spire Healthcare

Spire Healthcare is a leading independent healthcare group in the United Kingdom, running 38 hospitals and over 50 clinics, medical centres and consulting rooms across England, Wales and Scotland. It operates a network of private GPs and provides occupational health services to over 800 corporate clients.

Working in partnership with over 8,600 experienced consultants, Spire Healthcare delivered tailored, personalised care to over 1 million inpatients, outpatients and daycase patients, and occupational health programme clients, in 2023, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom. It also delivers a range of private and NHS mental health, musculoskeletal and dermatological services under the Vita Health Group brand.

Spire Healthcare's well-located and scalable hospitals have delivered successful and award-winning outcomes, positioning the group well with patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI') providers. 98% of Spire Healthcare's inspected locations are rated 'Good', 'Outstanding' or the equivalent by health inspectors in England, Wales and Scotland.

Spire Healthcare is listed on the London Stock Exchange and is a member of the FTSE 250.

 

END